Alison Hirukawa

Alison Hirukawa has a diverse work experience spanning various roles and companies. Alison is currently the co-founder CEO of DropGenie, a position they have held since June 2021. Prior to that, they were the co-founder and Chief of Product at DropGenie from April 2019 to May 2021. Additionally, they have been a Scientific Committee Member at MEDTEQ since September 2020, a role that is expected to continue until February 2023.

In terms of their academic background, Alison Hirukawa completed their PhD in Biochemistry at McGill University from September 2011 to June 2017. Alison'sdoctoral research focused on the role of epigenetics (H3K27me3) in breast cancer initiation, progression, and metastasis. Notably, their work has been published in Nature Communications.

Prior to their current roles, Alison worked as a Postdoctoral Research Fellow at the Goodman Cancer Research Centre at McGill University from October 2017 to June 2018. Alison also served as a BLUE fellow at Building 21 - McGill University from May 2018 to July 2018, where they developed a Virtual Reality installation using Unity Game engine and Blendr to facilitate the discovery of complex scientific concepts.

Overall, Alison Hirukawa's work experience showcases their expertise in biochemistry and their entrepreneurial skills as a co-founder and CEO.

Alison Hirukawa completed their Bachelor of Science, Honours degree at Queen's University, with a major in Biology and a minor in Philosophy. Alison then pursued a Master of Science in Medical Genetics at The University of British Columbia. Subsequently, they obtained their PhD in Biochemistry from McGill University.